Literature DB >> 23557789

Bone mineral density 5 years after parathyroidectomy in hemodialysis patients with secondary hyperparathyroidism.

Masayuki Yamanouchi1, Yoshifumi Ubara, Noriko Hayami, Tatsuya Suwabe, Rikako Hiramatsu, Keiichi Sumida, Eiko Hasegawa, Junichi Hoshino, Naoki Sawa, Kiho Tanaka, Yuji Marui, Michio Nakamura, Shinji Tomikawa, Kennmei Takaichi.   

Abstract

BACKGROUND: Whether bone mineral density (BMD) is improved at 5 years after parathyroidectomy (PTx) for secondary hyperparathyroidism (SHPT) remains unknown.
OBJECTIVE: To investigate BMD after PTx by dual energy X-ray absorptiometry (DXA).
METHODS: BMD was measured at the distal 1/3 of the radius (non-shunt side) and at the lumbar supine (L2-L4, lateral view) before and 5 years after PTx in 35 hemodialysis patients who had undergone surgery from April 1994 to May 2004. The data were analyzed retrospectively.
RESULTS: Intact PTH decreased significantly from 1,100 ± 530 (range: 446 - 2,300) pg/ ml before PTx to 75 ± 68 (2 - 251) pg/ml at 5 years after PTx (p < 0.01). Before PTx, the radial BMD and lumbar BMD were both decreased -3.3 ± 1.9 SD and -1.3 ± 2.4 SD compared with the corresponding normal mean T-score, respectively. Radial BMD increased significantly from 0.522 ± 0.113 g/cm2 before PTx to 0.545 ± 0.114 g/cm2 (p = 0.01) at 5 years after PTx, while the T-score improved to -2.8 ± 2.0 SD. In contrast, lumbar BMD showed no significant change between before (0.734 ± 0.202 g/cm2) and 5 years after PTx (0.746 ± 0.199 g/cm2), and neither did the T-score (-1.1 ± 2.3 SD). None of the patients suffered any fractures during follow up.
CONCLUSION: These findings indicate that maintaining iPTH at < 300 pg/ml for 5 years after PTx results in an increase of radial BMD in SHPT patients with preoperative BMD levels in the osteoporosis range (below -2.5 SD) according to the WHO, as well as stabilizing lumbar BMD.

Entities:  

Mesh:

Year:  2013        PMID: 23557789     DOI: 10.5414/CN107661

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

Review 1.  Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.

Authors:  S N Salam; A Khwaja; M E Wilkie
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

2.  The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism.

Authors:  Shuangxin Liu; Weiping Zhu; Sijia Li; Tongxia Cui; Zhonghe Li; Bin Zhang; Zhuo Li; Jianxiong Wu; Xinling Liang; Zheng Lin; Wei Shi
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.